Clinical Stage III Gastric Cancer AJCC v8 Recruiting Phase 2 Trials for Ramucirumab (DB05578)

IndicationStatusPhase
DBCOND0113386 (Clinical Stage III Gastric Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04660760Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction CancerTreatment